<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03689842</url>
  </required_header>
  <id_info>
    <org_study_id>2016/26</org_study_id>
    <nct_id>NCT03689842</nct_id>
  </id_info>
  <brief_title>Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)</brief_title>
  <official_title>Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In France, one in 4500 women is affected by the MayerRokitantskyKüsterHauser (MRKH) syndrome
      which is characterized by the absence of uterus at birth. Currently, the only solutions for
      these patients are:

        -  Gestational surrogacy, prohibited in France

        -  Adoption

        -  Resignation

      Uterine transplantation could become a good alternative.

      This study is conducted in 10 patients with MRKH type I syndrome, who will be transplanted
      from a living donor uterus
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to obtain a pregnancy after uterine transplantation from a living
      donor. Also, this study will assess (anatomically and functionally) the issue of the
      transplants of a uterus taken from a living donor and the safety of the living donor
      (functionally and psychologically)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 14, 2017</start_date>
  <completion_date type="Anticipated">June 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 14, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pregnancy</measure>
    <time_frame>3 years</time_frame>
    <description>Obtaining of a pregnancy after uterine transplantation from a living donor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety assessment of the donor, the recipient and the fœtus</measure>
    <time_frame>7 years</time_frame>
    <description>Monitoring of all the Adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological assessment of the donor and the recipient</measure>
    <time_frame>7 years</time_frame>
    <description>Psychological consequences linked to the procedure determined by repeated interviews with psychologists</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Graft Rejection assessment</measure>
    <time_frame>5 years</time_frame>
    <description>Donor-specific antobodies monitoring</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Mayer Rokitansky Kuster Hauser Syndrome</condition>
  <arm_group>
    <arm_group_label>Couple donor - recipient</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Uterine transplantation</intervention_name>
    <description>Uterine transplantation from living donor</description>
    <arm_group_label>Couple donor - recipient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Graft recipient is a patient with Mayer-Rokitansky-Küster-Hauser Type I Uterine Vaginal
        Agenesis (without renal, cardiac and bone malformations):

          -  Being aged between 18 and 38 years old

          -  In stable couple, with a pregnancy project, favorable psychological evaluation

          -  No history of cancer and transfusion

        The living donor is a woman related to the Graft recipient with

          -  Absence of comorbidity (neurological, nephro-urological pathology, infectious,
             psychiatric or psychological pathology)

          -  Absence of uterine surgery, abdomino-pelvic major pathology history

        Exclusion Criteria:

        Graft recipient:

          -  Extreme oligo-astheno-spermia and azoospermia in the husband

          -  History of abdominopelvic surgery excluding uncomplicated appendectomy; vaginal
             residue not allowing anastomosis

        Living donor :

          -  Known thromboembolic risk factor

          -  No Compatibility with the recipient (group, rhesus, HLA)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hopital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Marc Ayoubi, MD PhD</last_name>
      <phone>+33(0)146252339</phone>
      <email>jm.ayoubi@hopital-foch.org</email>
    </contact>
    <investigator>
      <last_name>Jean-Marc Ayoubi, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>René Frydman, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie Carbonnel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurélie Revaux, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Goetgheluck J, Carbonnel M, Ayoubi JM. Robotically assisted gynecologic surgery: 2-year experience in the French foch hospital. Front Surg. 2014 May 5;1:8. doi: 10.3389/fsurg.2014.00008. eCollection 2014.</citation>
    <PMID>25593933</PMID>
  </reference>
  <reference>
    <citation>Brännström M, Johannesson L, Bokström H, Kvarnström N, Mölne J, Dahm-Kähler P, Enskog A, Milenkovic M, Ekberg J, Diaz-Garcia C, Gäbel M, Hanafy A, Hagberg H, Olausson M, Nilsson L. Livebirth after uterus transplantation. Lancet. 2015 Feb 14;385(9968):607-616. doi: 10.1016/S0140-6736(14)61728-1. Epub 2014 Oct 6.</citation>
    <PMID>25301505</PMID>
  </reference>
  <reference>
    <citation>Carbonnel M, Abbou H, N'guyen HT, Roy S, Hamdi G, Jnifen A, Ayoubi JM. Robotically Assisted Hysterectomy versus Vaginal Hysterectomy for Benign Disease: A Prospective Study. Minim Invasive Surg. 2013;2013:429105. doi: 10.1155/2013/429105. Epub 2013 Jul 7.</citation>
    <PMID>23936645</PMID>
  </reference>
  <reference>
    <citation>Gauthier T, Lavoue V, Piver P, Aubard Y, Ayoubi JM, Garbin O, Agostini A, Collinet P, Morcel K; Comité d’étude de la Transplantation Utérine en France (CETUF) du CNGOF. Which neovagina reconstruction procedure for women with Mayer-Rokitansky-Küster-Hauser syndrome in the uterus transplantation era? Editorial from the French Uterus Transplantation Committee (CETUF) of CNGOF. J Gynecol Obstet Hum Reprod. 2018 Apr;47(4):175-176. doi: 10.1016/j.jogoh.2018.01.003. Epub 2018 Jan 31.</citation>
    <PMID>29391294</PMID>
  </reference>
  <reference>
    <citation>Grynberg M, Ayoubi JM, Bulletti C, Frydman R, Fanchin R. Uterine transplantation: a promising surrogate to surrogacy? Ann N Y Acad Sci. 2011 Mar;1221:47-53. doi: 10.1111/j.1749-6632.2011.05952.x. Review.</citation>
    <PMID>21401629</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 13, 2018</study_first_submitted>
  <study_first_submitted_qc>September 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2018</study_first_posted>
  <last_update_submitted>August 13, 2019</last_update_submitted>
  <last_update_submitted_qc>August 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>46, XX Disorders of Sex Development</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

